SCHEMBL29343238

SCHEMBL29343238

CCOC(=O)c1nn(PC)cc1C(O)c1nc(Br)cs1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 4/20 0.33
▸ ADORA2A P29274 3/20 0.33
▸ ADORA1 P30542 3/20 0.33
▸ NPC1 O15118 5/20 0.33
▸ RAB9A P51151 5/20 0.33
▸ MAPT P10636 5/20 0.33
▸ LMNA P02545 2/20 0.33
▸ RXFP1 Q9HBX9 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ ALDH1A1 P00352 5/20 0.33
▸ MEN1 O00255 5/20 0.33
▸ KMT2A Q03164 5/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ GAA P10253 2/20 0.32
▸ ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29342224 0.76 NPC1 (0.45) ADORA3ADORA2AADORA1NPC1RAB9A
SCHEMBL30527355 0.69 MAPT (0.40) NPC1RAB9AMAPTLMNARXFP1
SCHEMBL1476131 0.64 MAPT (0.47) NPC1RAB9AMAPTRXFP1NPSR1
SCHEMBL29342233 0.64 SMN1; SMN2 (0.47) ADORA3ADORA2AADORA1NPC1RAB9A
SCHEMBL29343229 0.63 ADORA1 (0.36) ADORA3ADORA2AADORA1NPC1RAB9A
SCHEMBL29159855 0.62 RAB9A (0.48) NPC1RAB9AMAPTLMNARXFP1
SCHEMBL25776846 0.61 ALDH1A1 (0.36) NPC1RAB9AMAPTLMNARXFP1
SCHEMBL29053898 0.61 ALDH1A1 (0.36) NPC1RAB9AMAPTLMNARXFP1
SCHEMBL15614503 0.59 ADORA2A (0.50) ADORA3ADORA2AADORA1NPC1RAB9A
SCHEMBL12548274 0.59 RAB9A (0.59) NPC1RAB9AMAPTRXFP1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF UACA, ADCYAP1R1, ADCY1 ADORA3 1081/4885ADORA2A 1052/4885ADORA1 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback